The dual-function CD150 receptor subfamily: the viral attraction
暂无分享,去创建一个
[1] M. López-Botet,et al. Cloning of two new splice variants of Siglec-10 and mapping of the interaction between Siglec-10 and SHP-1. , 2002, Biochemical and biophysical research communications.
[2] R. Cattaneo,et al. Efficiency of Measles Virus Entry and Dissemination through Different Receptors , 2002, Journal of Virology.
[3] K. Yamanishi,et al. Human Herpesvirus 6 Variant A but Not Variant B Induces Fusion from Without in a Variety of Human Cells through a Human Herpesvirus 6 Entry Receptor, CD46 , 2002, Journal of Virology.
[4] S. Tangye,et al. CD84 is up‐regulated on a major population of human memory B cells and recruits the SH2 domain containing proteins SAP and EAT‐2 , 2002, European journal of immunology.
[5] V. ter meulen,et al. Analysis of receptor (CD46, CD150) usage by measles virus. , 2002, The Journal of general virology.
[6] M. Blixenkrone-Møller,et al. Measles virus-induced modulation of host-cell gene expression. , 2002, Journal of General Virology.
[7] R. Tan,et al. Association of the X-linked Lymphoproliferative Disease Gene Product SAP/SH2D1A with 2B4, a Natural Killer Cell-activating Molecule, Is Dependent on Phosphoinositide 3-Kinase* , 2002, The Journal of Biological Chemistry.
[8] R. Biassoni,et al. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] C. Terhorst,et al. Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation. , 2002, Blood.
[10] G. Freeman,et al. The B7–CD28 superfamily , 2002, Nature Reviews Immunology.
[11] V. ter meulen,et al. Regulation of gene expression in lymphocytes and antigen-presenting cells by measles virus: consequences for immunomodulation , 2002, Journal of Molecular Medicine.
[12] Qiong Shen,et al. Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family , 2002, Immunogenetics.
[13] S. S. Chuang,et al. 2B4 (CD244)-Mediated Activation of Cytotoxicity and IFN-γ Release in Human NK Cells Involves Distinct Pathways1 , 2001, The Journal of Immunology.
[14] Y. Yanagi,et al. Induction of the measles virus receptor SLAM (CD150) on monocytes. , 2001, The Journal of general virology.
[15] M. Colonna,et al. Cutting Edge: Activation of NK Cell-Mediated Cytotoxicity by a SAP-Independent Receptor of the CD2 Family1 , 2001, The Journal of Immunology.
[16] T. Okazaki,et al. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] Massimo Morra,et al. Structural basis for the interaction of the free SH2 domain EAT‐2 with SLAM receptors in hematopoietic cells , 2001, The EMBO journal.
[18] Bela Tiwari,et al. CD2F-10: a new member of the CD2 subset of the immunoglobulin superfamily , 2001, Immunogenetics.
[19] T. Derfuss,et al. Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity , 2001, European journal of immunology.
[20] J. Jung,et al. Abnormal T Cell Receptor Signal Transduction of CD4 Th Cells in X-Linked Lymphoproliferative Syndrome1 , 2001, The Journal of Immunology.
[21] O. Silander,et al. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. , 2001, Blood.
[22] E. Meinl,et al. Signaling Lymphocytic Activation Molecule Is Expressed on Mature CD83+ Dendritic Cells and Is Up-Regulated by IL-1β1 , 2001, The Journal of Immunology.
[23] L. Notarangelo,et al. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. , 2001, The Journal of experimental medicine.
[24] T. Pawson,et al. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product , 2001, Nature Immunology.
[25] M. Bennett,et al. 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes , 2001, Immunological reviews.
[26] Y. Yanagi,et al. Morbilliviruses Use Signaling Lymphocyte Activation Molecules (CD150) as Cellular Receptors , 2001, Journal of Virology.
[27] P. Engel,et al. CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells , 2001, Immunogenetics.
[28] P. Engel,et al. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. , 2001, Blood.
[29] A. Sher,et al. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Latour,et al. Proximal protein tyrosine kinases in immunoreceptor signaling. , 2001, Current opinion in immunology.
[31] V. ter meulen,et al. CD150 (SLAM) Is a Receptor for Measles Virus but Is Not Involved in Viral Contact-Mediated Proliferation Inhibition , 2001, Journal of Virology.
[32] P. Borrow,et al. SAP controls T cell responses to virus and terminal differentiation of TH2 cells , 2001, Nature Immunology.
[33] Y. Yanagi,et al. Measles Viruses on Throat Swabs from Measles Patients Use Signaling Lymphocytic Activation Molecule (CDw150) but Not CD46 as a Cellular Receptor , 2001, Journal of Virology.
[34] K. Nichols,et al. CD150 Association with Either the SH2-Containing Inositol Phosphatase or the SH2-Containing Protein Tyrosine Phosphatase Is Regulated by the Adaptor Protein SH2D1A1 , 2001, The Journal of Immunology.
[35] L. A. Feeney,et al. Cloning, Expression, and Function of BLAME, a Novel Member of the CD2 Family , 2001, The Journal of Immunology.
[36] V. ter meulen,et al. Measles virus induced immunosuppression: targets and effector mechanisms. , 2001, Current molecular medicine.
[37] M. Kirkitadze,et al. Structure and flexibility of the multiple domain proteins that regulate complement activation , 2001, Immunological reviews.
[38] R. Clementi,et al. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. , 2001, Blood.
[39] Y. Yanagi,et al. V Domain of Human SLAM (CDw150) Is Essential for Its Function as a Measles Virus Receptor , 2001, Journal of Virology.
[40] C. Richardson,et al. CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. , 2001, Virology.
[41] D. Nelson,et al. X–linked lymphoproliferative syndrome , 2000, Clinical and experimental immunology.
[42] G. Klein,et al. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. , 2000, Blood.
[43] L. Szekely,et al. SH2D1A and slam protein expression in human lymphocytes and derived cell lines , 2000, International journal of cancer.
[44] G. Darai,et al. Mapping of mRNA Transcripts in the Genome of Molluscum Contagiosum Virus: Transcriptional Analysis of the Viral Slam Gene Family , 2000, Virus Genes.
[45] B. Neel,et al. New Role for Shc in Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway , 2000, Molecular and Cellular Biology.
[46] H. Pabst,et al. Cutting Edge: Defective NK Cell Activation in X-Linked Lymphoproliferative Disease1 , 2000, The Journal of Immunology.
[47] S. Tangye,et al. Cutting Edge: Functional Requirement for SAP in 2B4-Mediated Activation of Human Natural Killer Cells as Revealed by the X-Linked Lymphoproliferative Syndrome1 , 2000, The Journal of Immunology.
[48] D I Stuart,et al. Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. , 2000, The Journal of biological chemistry.
[49] Y. Yanagi,et al. SLAM (CDw150) is a cellular receptor for measles virus , 2000, Nature.
[50] L. Notarangelo,et al. X-Linked Lymphoproliferative Disease 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected Cells , 2000 .
[51] M. Gold,et al. Targets of B‐cell antigen receptor signaling: the phosphatidylinositol 3‐kinase/Akt/glycogen synthase kinase‐3 signaling pathway and the Rap1 GTPase , 2000, Immunological reviews.
[52] C. Terhorst,et al. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus. , 2000, Current opinion in immunology.
[53] A. Jacob,et al. Enzymatic Activity of the Src Homology 2 Domain-containing Inositol Phosphatase Is Regulated by a Plasma Membrane Location* , 2000, The Journal of Biological Chemistry.
[54] E. Kieff,et al. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[55] S. Tangye,et al. 2B4-mediated activation of human natural killer cells. , 2000, Molecular immunology.
[56] S. Tangye,et al. The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. , 2000, Seminars in immunology.
[57] P. Vidalain,et al. Measles Virus Induces Abnormal Differentiation of CD40 Ligand-Activated Human Dendritic Cells1 , 2000, The Journal of Immunology.
[58] Meindl,et al. Recurrent B‐cell non‐Hodgkin's lymphoma in two brothers with X‐linked lymphoproliferative disease without evidence for Epstein–Barr virus infection , 2000, British journal of haematology.
[59] T. Pawson,et al. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A , 1999, Current Biology.
[60] S. Tangye,et al. Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. , 1999, Journal of immunology.
[61] W. Friedrich,et al. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). , 1999, Human molecular genetics.
[62] C Terhorst,et al. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. , 1999, Molecular cell.
[63] M. Clerici,et al. Altered signaling lymphocytic activation molecule (SLAM) expression in HIV infection and redirection of HIV-specific responses via SLAM triggering. , 1999, Clinical immunology.
[64] S. Tangye,et al. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. , 1999, Journal of immunology.
[65] L. M. Shlapatska,et al. CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis. , 1999, Journal of immunology.
[66] A. DeFranco,et al. The Src Homology Domain 2-Containing Inositol Phosphatase SHIP Forms a Ternary Complex with Shc and Grb2 in Antigen Receptor-stimulated B Lymphocytes* , 1999, The Journal of Biological Chemistry.
[67] E. Snyder,et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[68] E. Kieff,et al. Why commonplace encounters turn to fatal attraction , 1998, Nature Genetics.
[69] D. Allen,et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM , 1998, Nature.
[70] Jack R. Davis,et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene , 1998, Nature Genetics.
[71] G. Klein,et al. Immunology: Sinking surveillance's flagship , 1998, Nature.
[72] C. Rabourdin-Combe,et al. Measles Virus Suppresses Cell-mediated Immunity by Interfering with the Survival and Functions of Dendritic and T Cells , 1997, The Journal of experimental medicine.
[73] E. Koonin,et al. The genome of molluscum contagiosum virus: analysis and comparison with other poxviruses. , 1997, Virology.
[74] B. Cocks,et al. SLAM and its role in T cell activation and Th cell responses , 1997, Immunology and cell biology.
[75] B. Cocks,et al. Soluble and Membrane-bound Forms of Signaling Lymphocytic Activation Molecule (SLAM) Induce Proliferation and Ig Synthesis by Activated Human B Lymphocytes , 1997, The Journal of experimental medicine.
[76] E. Koonin,et al. Genome Sequence of a Human Tumorigenic Poxvirus: Prediction of Specific Host Response-Evasion Genes , 1996, Science.
[77] S. P. Sidorenko,et al. Immunodeficiency virus cDNA synthesis in resting T lymphocytes is regulated by T cell activation signals and dendritic cells , 1996, Journal of medical primatology.
[78] B. Cocks,et al. A novel receptor involved in T-cell activation , 1995, Nature.
[79] N. Beauchemin,et al. Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses , 1994, Journal of virology.
[80] S. P. Sidorenko,et al. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. , 1993, Journal of immunology.
[81] A. Nomoto,et al. Functional domains of the poliovirus receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[82] G. Darai,et al. Poxvirus Homologues of Cellular Genes , 2004, Virus Genes.
[83] S. Latour,et al. Negative regulation of immunoreceptor signaling. , 2002, Annual review of immunology.
[84] K. Tanaka,et al. The measles virus hemagglutinin downregulates the cellular receptor SLAM (CD150) , 2002, Archives of Virology.
[85] P. Engel,et al. X-linked lymphoproliferative disease: a progressive immunodeficiency. , 2001, Annual review of immunology.
[86] H. Ploegh,et al. Viral subversion of the immune system. , 2000, Annual review of immunology.
[87] M. Colonna,et al. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism. , 2000, Human immunology.
[88] O. Yurchenko,et al. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping. , 1992, Neoplasma.